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We generated a neonatal pig model with human infant gut microbiota (HGM) to study the effect of a probiotic on
the composition of the transplanted microbiota following rotavirus vaccination and challenge. All the
HGM-transplanted pigs received two doses of an oral attenuated rotavirus vaccine. The gut microbiota of
vaccinated pigs were investigated for effects of Lactobacillus rhamnosus GG (LGG) supplement and homotypic
virulent human rotavirus (HRV) challenge. High-throughput sequencing of V4 region of 16S rRNA genes
demonstrated that HGM-transplanted pigs carried microbiota similar to that of the C-section delivered baby.
Firmicutes and Proteobacteria represented over 98% of total bacteria in the human donor and the recipient pigs.
HRV challenge caused a phylum-level shift from Firmicutes to Proteobacteria. LGG supplement prevented the
changes in microbial communities caused by HRV challenge. In particular, members of Enterococcus in
LGG-supplemented pigs were kept at the baseline level, while they were enriched in HRV challenged pigs. Taken
together, our results suggested that HGM pigs are valuable for testing the microbiota’s response to probiotic
interventions for treating infantile HRV infection.
Keywords: Microbiota, Gnotobiotic pigs, Rotavirus, Vaccine, Lactobacillus, ProbioticsIntroduction
Humanized microbiota models, such as germ-free animals
transplanted with human feces, are valuable for studying
microbiota composition change due to external factors by
minimizing confounding variables [1,2]. Gnotobiotic (Gn)
pigs provide an excellent model for isolating microbiota as
an environmental factor in disease models [3] because pigs
and human share high genome homology (98%), similar
intestinal anatomy, physiology, immune systems, nutri-
tional requirements, and food transit times [4-6]. Both
pigs and human are also susceptible to human rotavirus
Wa strain (genotype G1P [7]) infection and disease [8].
Human rotavirus (HRV) infection is the leading cause
of gastroenteritis in infants and children, especially in* Correspondence: lyuan@vt.edu
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unless otherwise stated.developing countries [7]. The burden is exacerbated for
infants and young children in the developing world, be-
cause many of them have a weak immune response to
oral rotavirus vaccines and the protective efficacies of
the vaccines are lower compared to that in the devel-
oped world [9]. The gut microbiota’s response to rota-
virus infection has not been systematically investigated;
despite that, microbiota disruption (intestinal dysbiosis)
may be a risk factor for long-term adverse effects. Rota-
virus infection in humans was found to be associated
with an increase in Bacteroides fragilis and decreased B.
vulgatus and B. stercoris in a clone-library study [10].
However, a comprehensive analysis is lacking for the ef-
fect of therapeutic interventions such as vaccination and
probiotics on rotavirus-infected gut microbiota.
Orally administered probiotic bacterium Lactobacillus
rhamnosus GG (LGG) has been tested in numerous clin-
ical trials to prevent or shorten rotavirus-induced diarrhea
[11,12]. Supplementation with LGG for 4 weeks after
acute rotavirus infection reduced intestinal permeability inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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subsequent diarrheal episodes and increased IgG anti-
body response [13]. Lactobacilli have also been impli-
cated in lipid metabolism due to their bile salt hydrolase
activities [14]. We hypothesized that the beneficial ef-
fects of LGG against rotavirus-related diarrhea may be a
result of modulating the intestinal microbiota towards a
healthier profile.
We aimed to determine how rotavirus infection affects
the human gut microbiota inoculated in Gn pigs and
whether probiotic LGG can prevent the disruption of the
microbiota. We transplanted human infant fecal micro-
biota to newborn Gn pigs. The pigs were or were not
treated with a daily dose of LGG for 2 weeks, vaccinated
with an oral attenuated HRV vaccine, and subsequently
challenged or not challenged with virulent HRV. We in-
vestigated: (a) how efficiently different bacterial species
in the human gut microbiota (HGM) colonize neonatal
germ-free pigs, (b) the associative changes in the micro-
biota in response to HRV challenge, and (c) whether
LGG, HRV and interactions between LGG and HRV
have effects on the gut microbial community structure.
Materials and methods
Ethics statement
All animal experiments were performed in strict accord-
ance with federal and university guidelines. Specifically,
we adhered to the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institutes of Health and the American Veterinary Med-
ical Association Guidelines on Euthanasia. The animal
protocol was approved by the Institutional Animal Care
and Use Committee at Virginia Tech (Protocol# 10-168-
CVM and 13-187-CVM). Ethical Committee approval
was received from Virginia Tech Institutional Review
Board for the newborn human stool sample collection
(IRB number 11–1049).
Transplantation of HGM into Gn pigs
Gn pigs were derived by hysterectomy from near-term
sows (Landrace and Large White crossbred) and main-
tained in germ-free isolator units [8,15]. Pigs of the same
treatment groups were housed in individual 4-place iso-
lators. The pigs were fed ultra-high-temperature steril-
ized milk (Hershey) throughout the experiment.
Multiple stool samples from a cesarean-section deliv-
ered, exclusively breast-fed healthy infant at 17–23 days
of age were collected and made into an inoculum pool
to generate HGM pigs. Briefly, daily collected fresh stool
was diluted 20-fold in sterile pre-reduced PBS (pH 7.2)
and glycerol (15% by volume) and stored at −80°C under
an atmosphere of nitrogen. A week-long multiple stool
samples were pooled and homogenized for use in the
entire course of the experiment. Prior to inoculation, thehuman stool was screened for pathogens as previously de-
scribed [16]. The screening showed no hemolytic activity.
Next-generation sequencing at Viral Diagnostics and Dis-
covery Center at UCSF showed no known viruses in the
sample. Pigs were orally inoculated with the human stool
inoculum (1 ml of 5% stool suspension in PBS) once daily
starting at 12 hours after birth for three days to establish
the HGM in Gn pigs. The timing of HGM inoculation is
to mimic the natural microbial colonization of the new-
born’s gut (within hours after birth).
Inoculation of Gn pigs with attenuated HRV vaccine,
virulent HRV and probiotics (LGG)
The cell-culture adapted attenuated HRV Wa strain
(G1P1A [7]) was used as the vaccine at a dose of 5 × 107
fluorescent focus forming units (FFU) [8]. The virulent
HRV Wa strain was passaged through Gn pigs and the
pooled intestinal contents were used for challenge of Gn
pigs at a dose of ~105 FFU [17]. The virus titer was de-
termined by using cell culture immunofluorescence
(CCIF) assay and was expressed as FFU/ml as described
previously [18]. Probiotic LGG (ATCC# 53103) was
propagated in Lactobacilli MRS broth (Weber, Hamilton,
NJ, USA). LGG inoculums were prepared and titrated as
previously described [19].
All the HGM pigs received two dose of the oral atten-
uated HRV vaccine at 5 and 15 days of age. The purpose
of the vaccination is to study the effects of LGG in en-
hancing the immunogenicity of rotavirus vaccines in the
HGM pigs, which was the objective of another concur-
rent study [16]. The HGM-transplanted and vaccinated
pigs were divided into four groups: (a) no LGG feeding,
no virulent HRV challenge (−LGG-HRV, n = 4), (b) no
LGG feeding, with HRV challenge (−LGG +HRV, n = 4),
(c) with LGG feeding, no HRV challenge (+LGG-HRV, n
= 4), and (d) with both LGG feeding and HRV challenge
(+LGG +HRV, n = 3, one pig was euthanized prior to
the scheduled time due to health problems). Daily LGG
feeding started at 3 days of age for 14 days (3–16 days of
age) with 10-fold incremental LGG dose increase every
day (from 103 to 109 CFU/dose) as previously described
[19]. LGG was administrated in 3 ml of 0.1% peptone
water. Non-LGG fed pigs were given 3 ml of 0.1% pep-
tone water but no LGG. Pigs in the + HRV groups were
challenged with the virulent HRV at post-attenuated
HRV inoculation day (PID) 28. Pigs were euthanized at
PID 28 before challenge (−LGG-HRV and + LGG-HRV
groups) or at post-challenged day (PCD) 7 (−LGG +HRV
and + LGG+HRV groups). The pig body weight at eu-
thanasia did not differ among different treatment groups.
Colonic contents and serum samples were collected at eu-
thanasia as previously described [16]. After virulent HRV
challenge, rotavirus diarrhea and fecal virus shedding were
monitored from PCD 1 to 7 (14).
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Colonic contents from the pig large intestine were col-
lected at euthanasia and stored at −80°C. DNA from hu-
man stools and pig intestinal contents was extracted
with the QIAamp stool mini kit following manufacture’s
instructions. The 16S rRNA gene amplicons were gener-
ated by PCR with 515 F and barcoded 806R primers
[20]. Purified amplicons were sequenced with Illumina
MiSeq™.
Sequencing reads were processed with Quantitative In-
sights Into Microbial Ecology (QIIME) [21]. High quality
reads with Phred quality score ≥20 (corresponding to an
sequencing error rate ≤ 0.01) were clustered into oper-
ational taxonomic units (OTUs) with the program
UCLUST [22]. Chimeric sequences were identified with
CHIMERASLAYER [23] and removed from further ana-
lysis. Bacterial taxonomy was assigned by using a naïve
Bayes classifier [24] against reference databases and
bacterial taxonomy maps at Greengenes [25]. A phylo-
genetic tree was constructed [26] from PyNAST-aligned
sequences representing each OTU. Principle coordinateFigure 1 Bacterial taxonomic summary for the human donor and the
level (for genera collectively accounting for more than 0.5% of total comm
(HRV) challenge are designated as ± LGG or ± HRV, respectively. For exampl
B: HRV infection changes the relative abundance of Proteobacteria and Firm
mean. The p values are based on Mann–Whitney test. The statistical signific
log-transformed data. C: Combination of LGG and HRV changes relative ab
relative abundance of Streptococcus. The p values in C and D were based oanalysis on stool samples was based on UniFrac dis-
tances [27]. Distance-based redundancy analysis for ef-
fect of HRV on community structures was performed
with the VEGAN package [28]. Shannon and Simpson
diversity indices and a rank abundance curve were both
generated with QIIME.
The nucleotide sequences have been deposited to MG-
RAST [29] with the accession number 4547774.3. Com-
parison of data with respect to LGG and HRV treatment
was done with unpaired t-tests, Mann–Whitney test
without assuming normal distributions, One-Way or
Two-Way ANOVA.
Results
A total of 5,616,353 non-chimeric high quality sequences
from feces of the human donor and the recipient pigs
were analyzed with QIIME. We analyzed the sequences
at the operational taxonomic unit (OTU) level [30]. The
recipient pigs carried microbiota that are similar to the
human donor’s microbiota (Figure 1A), despite that all
pigs had received the attenuated HRV vaccine. Tworecipient gnotobiotic pigs. A: Taxonomy breakdown at the genus
unity) for all subjects. Probiotic treatment and virulent human rotavirus
e, −LGG-HRV means no LGG treatment and no virulent HRV challenge.
icutes regardless of LGG. Error bars represent standard error of the
ance was the same when we used the unpaired t-test to
undance of Enterococcus. D: Combination of LGG and HRV changes
n Two-Way ANOVA.
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senting over 98% of total bacterial sequences in each
subject, dominated microbiota of both the human donor
(delivered by C-section) and the recipient pigs. The most
abundant genera within Firmicutes were Streptococcus,
Enterococcus,Veillonella, and Staphylococcus (Figure 1A).
The rank abundance curve showed that the gut micro-
biota of human and pigs had a long tail of rare OTUs
(Additional file 1: Figure S1). For example, around 900
OTUs (species rank from 100 to 1000) each accounted
only 0.01% (10−4) to well below 0.001% (10−5) of total
bacteria. The human gut microbiota represented by the
dashed line appeared to be above the gut microbiota of
recipient pigs, suggesting a slightly higher evenness of
human microbiota compared with pigs.
We observed a shift in the microbiota composition at
phylum, genus, and OTU levels. At the phylum level,
the relative abundance of Proteobacteria and Firmicutes
in transplanted pigs was affected by HRV challenge
(Figure 1B). HRV-challenged pigs had 16% less Firmicutes,
and accordingly 16% more Proteobacteria, than non-
challenged pigs. The significance of the shift was con-
firmed by Mann–Whitney test (P < 0.05 for both phyla).
The phyla Proteobacteria harbor many aerobes and facul-
tative anaerobes, and could serve important roles in re-
moving oxygen diffused from the gut epithelium [31].
We also found that HRV challenge was a factor in
changes in overall community structures at the OTU
level (Additional file 1: Figure S2), based on results from
distance-based redundancy analysis (db-RDA). At the
genus level, two abundant genera, Enterococcus and
Streptococcus, were affected by LGG feeding and HRV
challenge. In the absence of LGG feeding, HRV-
challenged pigs had significantly elevated Enterococcus
over non-challenged pigs (P < 0.01, Figure 1C). ThisFigure 2 Shannon (H) and Simpson (E) diversity indices of pig microb
donor microbiota are: H = 3.017 and E = 0.757. ns: not significant based oneffect was absent for pigs fed with LGG, indicating that
LGG prevented HRV’s effect on Enterococcus. In HRV-
challenged pigs, LGG-treated pigs again had signifi-
cantly reduced Enterococcus (P < 0.01, Figure 1C). HRV
decreased Streptococcus in pigs without LGG feeding (P <
0.05, Figure 1D), but the effect disappeared in LGG-fed
pigs, suggesting again that LGG prevented microbiota per-
turbation by rotavirus infection. The combination of LGG
and HRV also affected less abundant genera including
Veillonella and Aeromonas (data not shown). Similar to
our findings, an increase in Proteobacteria was reported in
norovirus-infected humans [32].
We were interested in whether HRV and/or LGG chan-
ged overall community richness and evenness. We found
that HRV challenge had no significant effect on Shannon
or Simpson diversity indices. LGG-treated microbiota ap-
peared to be slightly more diverse than untreated micro-
biota, but the effect was not significant (Figure 2).
To analyze LGG’s effect on microbial community struc-
tures, we performed principal coordinate analysis (PCoA)
on weighted UniFrac distances. The results showed that
LGG-treated pig microbiota was distinct from those re-
ceiving no LGG (Figure 3A), supported by a permutational
multivariate analysis (PERMANOVA) with a p value of
0.005 at 999 permutations [33]. The human microbiota
appeared to cluster closer with –LGG pigs. Figure 3B
showed that the extent to which HRV changed microbiota
depended on LGG. The HRV-caused microbiota change,
measured by UniFrac distances between +HRV and –
HRV pigs, was smaller for LGG treated pigs than for no-
LGG treated pigs (p < 0.001, Figure 3B), suggesting an
interaction between LGG and HRV on the microbiota
structure. Overall, LGG treatment could resist the
change of microbial community structures caused by
HRV challenge.iota with respect to LGG and HRV treatment. Values for the human
unpaired t-tests.
Figure 3 Phylogenetic dissimilarities among transplanted pigs and the effect of LGG treatment. A: A principal coordinate (PCoA) analysis
of weighted UniFrac distances among all pigs. Only the first two axes (PC1 and PC2) that explain largest variations among samples are plotted.
Open circles are pigs receiving no LGG, and filled triangles are pigs treated with LGG. The open square indicates the human microbiota.
Significant grouping by LGG was tested by PERMANOVA described in the text. B: The UniFrac distances between HRV-challenged pig microbiota
versus non-challenged pig microbiota. These distances were divided into two groups according to whether LGG was added. The test of
significance was performed using the Mann–Whitney test.
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In this study, we demonstrated that human gut micro-
biota could be transplanted to and colonize gnotobiotic
pigs. The resulting “humanized pigs” share the majority
of human donor microbiota, albeit the human donor
microbiota appeared to be more even than the colonized
pig gut microbiota. Virulent rotavirus challenge changed
Enterococcus and Streptococcus abundance in the hu-
manized pig microbiota. Adding probiotic LGG pre-
vented these changes.
The human infant microbiota used in our study was a
composite sample from a week-long daily collection of
feces. Our intention was to reduce the temporal variations
and dynamics known for human microbiota of this age
[34,35]. We acknowledge that effect of inter-personal
microbiota variations on colonization of Gn pigs would
need to be evaluated through the use of fecal samples
from a higher number of infants. Moreover, the inter-pig
variations in HGM colonization could be minimized
through the use of highly in-bred pigs. Overcoming these
limitations will allow us to quantify how stable the micro-
biota of recipient pigs are.
We chose a C-section delivered HGM donor in this
study because of the increasing popularity of this delivery
mode. The dominance of Firmicutes and Proteobacteria
while lacking Actinobacteria and Bacteroidetes is typical
for C-section delivered babies and different from vaginally-
delivered babies [36,37]. In particular, Bifidobacteria, a
prominent group in the phylum Actinobacteria, were ab-
sent in microbiota from C-section delivered infants, but
was found abundant in vaginally-delivered infants [36]. In
another high-throughput sequencing study, the mode of
delivery was found to be the main determinant ofnewborn’s microbiota [37]. In that study, C-section deliv-
ered babies lacked mothers’ vaginal species within Actino-
bacteria; Bacteroidetes was found to be mainly in the
vaginal delivered babies. The same study also reported that
Staphylococcus species appeared in C-section delivered ba-
bies, which agreed with our results (Figure 1A, Staphylo-
coccus in dark blue color).
Previous studies have demonstrated that the oral HRV
vaccine does not alter the gut microbiota in older children
[38]. This provided rationale for us not to include HMG
pigs without an HRV vaccine. All the Gn piglets in our
study were vaccinated with attenuated HRV, yet the
microbiota in the vaccinated pigs was still significantly al-
tered by virulent HRV (Figure 1B and Additional file 1:
Figure S2). We speculate that the extent of microbiota
alterations caused by virulent HRV would have been larger
if the Gn pigs were not vaccinated. This hypothesis war-
rants further investigation, as most children in developing
countries are not vaccinated against HRV. We found LGG
could prevent certain changes in microbiota induced by
HRV, suggesting potential interacting effects of LGG and
HRV on microbiota, although the exact nature of such in-
teractions is unclear.
Szajewska et al. [11] demonstrates that LGG improves
HRV-induced diarrhea. That study used subjects 1 month
to 18 years old but did not specify the delivery type. It is
possible that LGG may not have the same protective effects
on C-section delivered infants which contain a different
gut microbiota compared with vaginal delivered infants.
Although all the pigs studied received the oral attenuated
HRV vaccine, the protection against virulent HRV induced
diarrhea was only partial [16]. There were no significant
differences in protection rate against diarrhea or virus
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ding (data not shown); therefore we could not evaluate
quantitatively whether the changes in the microbiome cor-
relate with protection against diarrhea or virus shedding.
Fifty percent (2/4) of the pigs in the –LGG+HRV group
were protected from infection upon virulent HRV chal-
lenge. There is no apparent difference in the abundant taxa
between protected (Gp09.06 and Gp10.09) versus unpro-
tected (Gp10.10 and Gp10.11) pigs (Figure 1A, group
“-LGG+HRV”). However, the low abundance bacterial
taxa (Additional file 1: Figure S3), which accounted for less
than 0.5% of the microbiota, showed that one of the two
protected pigs (Gp09.06) harbored unique bacteria such
as Ruminococcaceae. The other protected pig (Gp10.09)
shared similar low-abundance taxa with unprotected pigs.
Further studies with more animals would be needed to
identify rare taxa potentially associated with viral
protection.
Several relevant issues that were not resolved in the
present study will be addressed in future studies. These
include (a) the effect of vaccination on the gut micro-
biota. (b) Microbiota in human infants varies among in-
dividuals and changes during the first few months of life,
especially at weaning. Our study used HGM from only
one C-section delivered newborn; a HGM mixture from
multiple older children matching the age of rotavirus
vaccination (e.g., 2 to 6 months) will be a better model
for vaccine evaluation. Additional data from both C-
section-derived and conventional birth-derived infants
would be highly desirable to further evaluation the
HGM pig model. (c) The LGG feeding in this study did
not significantly improve the protection conferred by the
rotavirus vaccine. Changes in the microbiome due to
LGG feeding were not associated with a change in the
protective efficacy of the vaccine. Adjustment of the
dose and dosing regimen of LGG may be needed in
order for LGG to exert its adjuvant effect on the rota-
virus vaccine. The microbiome structure and compos-
ition that may favor stronger immunogenicity and
protective efficacy of rotavirus vaccines require further
studies to identify.
In conclusion, the HGM-transplanted gnotobiotic pig
presents a useful model for testing interventions using
probiotics and vaccines to prevent or treat infantile diar-
rhea and improve enteric health and immunity. Future
study using a mixture of feces from multiple older chil-
dren that match the age of rotavirus vaccination will im-
prove this model for vaccine evaluation.
Additional file
Additional file 1: Figure S1. Relative abundance of OTUs plotted
against OTU rank. From left to right, high-ranking OTU with high
abundance towards low-ranking OTU with low abundance.Figure S2. Distance-based redundancy analysis (db-RDA) of pig
microbiota in response to HRV challenge. CAP1 and MDS1 are constrained
and unconstrained axes, respectively. HRV-challenged pigs are indicated by
ovals, and LGG supplemented pigs are indicated by underlines. The arrow
indicates source of variation explained by HRV. Figure S3. Rare taxa (OTUs
<0.5% of total bacteria) in the -LGG+HRV group. Gp09.06 and
Gp 10.09 were protected from infection by attenuated HRV vaccines.
Gp 10.10 and Gp10.11 were unprotected.
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